Evidence suggests that the gut microbiota might play an important role in fibromyalgia syndrome (FMS) and chronic fatigue syndrome (CFS). Our goal is to systematically review the reported effect of probiotic treatments in patients diagnosed with FMS or CFS. A systematic review was carried out using 14 databases (PubMed, Cochrane Library, Scopus, PsycINFO, and others) in February 2016 to search for randomised controlled trials (RCTs) and pilot studies of CFS or FMS patient, published in the last ten years (from 2006 to 2016). The Jadad scale was used to asseverate the quality of the clinical trials considered. Two studies (n=83) met the inclusion criteria, which were performed in CFS patients and both studies were considered as a ‘High range of quality score’. The administration of Lactobacillus casei strain Shirota in CFS patients, over the course of 8 weeks, reduced anxiety scores. Likewise, this probiotic changed the faecal composition following 8 weeks of treatment. Additionally, the treatment with Bifidobacterium infantis 35624 in CFS patients, during the same period, reduced inflammatory biomarkers. The evidence about the usefulness of probiotics in CFS and FMS patients remains limited. The studied strains of probiotics have demonstrated a significant effect on modulating the anxiety and inflammatory processes in CFS patients. However, more experimental research, focusing mainly on the symptoms of the pathologies studied, is needed.
Purchase
Buy instant access (PDF download and unlimited online access):
Institutional Login
Log in with Open Athens, Shibboleth, or your institutional credentials
Personal login
Log in with your brill.com account
Aaron, L.A. and Buchwald, D., 2001. A review of the evidence for overlap among unexplained clinical conditions. Annals of Internal Medicine 134: 868-881.
'A review of the evidence for overlap among unexplained clinical conditions ' () 134 Annals of Internal Medicine : 868 -881.
Aaron, L.A., Burke, M.M. and Buchwald, D., 2000. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Archives of Internal Medicine 160: 221-227.
'Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder ' () 160 Archives of Internal Medicine : 221 -227.
Akkasheh, G., Kashani-Poor, Z., Tajabadi-Ebrahimi, M., Jafari, P., Akbari, H., Taghizadeh, M., Memarzadeh, M.R., Asemi, Z. and Esmaillzadeh, A., 2016. Clinical and metabolic response to probiotic administration in patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial. Nutrition 32: 315-320.
'Clinical and metabolic response to probiotic administration in patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial ' () 32 Nutrition : 315 -320.
Benton, D., Williams, C. and Brown, A., 2007. Impact of consuming a milk drink containing a probiotic on mood and cognition. European Journal of Clinical Nutrition 61: 355-361.
'Impact of consuming a milk drink containing a probiotic on mood and cognition ' () 61 European Journal of Clinical Nutrition : 355 -361.
Bercik, P. and Collins, S.M., 2014. The effects of inflammation, infection and antibiotics on the microbiota-gut-brain axis. Advances in Experimental Medicine and Biology 817: 279-289.
'The effects of inflammation, infection and antibiotics on the microbiota-gut-brain axis ' () 817 Advances in Experimental Medicine and Biology : 279 -289.
Branco, J.C., Bannwarth, B., Failde, I., Abello Carbonell, J., Blotman, F., Spaeth, M., Saraiva, F., Nacci, F., Thomas, E., Caubère, J.P., Le Lay, K., Taieb, C. and Matucci-Cerinic, M., 2010. Prevalence of fibromyalgia: a survey in five European countries. Seminars in Arthritis and Rheumatism 39: 448-453.
'Prevalence of fibromyalgia: a survey in five European countries ' () 39 Seminars in Arthritis and Rheumatism : 448 -453.
Buchwald, D. and Garrity, D., 1994. Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities. Archives of Internal Medicine 154(18): 2049-2053.
'Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities ' () 154 Archives of Internal Medicine : 2049 -2053.
Butt, H., Dunstan, R., McGregor, N. and Roberts, T., 2001. Bacterial colonosis in patients with persistent fatigue. Myalgic encephalopathy: chronic fatigue syndrome meeting. Sydney, Australia.
'Bacterial colonosis in patients with persistent fatigue', ().
Carabotti, M., Scirocco, A., Maselli, M.A. and Severi, C., 2015. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Annals of Gastroenterology 28: 203-209.
'The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems ' () 28 Annals of Gastroenterology : 203 -209.
Clark, H.D., Wells, G.A., Huët, C., McAlister, F.A., Salmi, L.R., Fergusson, D. and Laupacis, A., 1999. Assessing the quality of randomized trials: reliability of the Jadad scale. Controlled Clinical Trials 20: 448-452.
'Assessing the quality of randomized trials: reliability of the Jadad scale ' () 20 Controlled Clinical Trials : 448 -452.
Cryan, J.F. and Dinan, T.G., 2012. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nature Reviews Neuroscience 13: 701-712.
'Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour ' () 13 Nature Reviews Neuroscience : 701 -712.
Cryan, J.F. and O’Mahony, S.M., 2011. The microbiome-gut-brain axis: from bowel to behavior. Neurogastroenterology and Motility 23: 187-192.
'The microbiome-gut-brain axis: from bowel to behavior ' () 23 Neurogastroenterology and Motility : 187 -192.
Dapoigny, M., Piche, T., Ducrotte, P., Lunaud, B., Cardot, J.-M. and Bernalier-Donadille, A., 2012. Efficacy and safety profile of LCR35 complete freeze-dried culture in irritable bowel syndrome: a randomized, double-blind study. World Journal of Gastroenterology 18: 2067-2075.
'Efficacy and safety profile of LCR35 complete freeze-dried culture in irritable bowel syndrome: a randomized, double-blind study ' () 18 World Journal of Gastroenterology : 2067 -2075.
De Palma, G., Collins, S.M., Bercik, P. and Verdu, E.F., 2014. The microbiota-gut-brain axis in gastrointestinal disorders: stressed bugs, stressed brain or both? Journal of Physiology 592: 2989-2997.
'The microbiota-gut-brain axis in gastrointestinal disorders: stressed bugs, stressed brain or both? ' () 592 Journal of Physiology : 2989 -2997.
Desbonnet, L., Garrett, L., Clarke, G., Bienenstock, J. and Dinan, T.G., 2008. The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat. Journal of Psychiatric Research 43: 164-174.
'The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat ' () 43 Journal of Psychiatric Research : 164 -174.
Diaz Heijtz, R., Wang, S., Anuar, F., Qian, Y., Björkholm, B., Samuelsson, A., Hibberd, M.L., Forssberg, H. and Pettersson, S., 2011. Normal gut microbiota modulates brain development and behavior. Proceedings of the National Academy of Sciences of the USA 108: 3047-3052.
'Normal gut microbiota modulates brain development and behavior ' () 108 Proceedings of the National Academy of Sciences of the USA : 3047 -3052.
Didari, T., Mozaffari, S., Nikfar, S. and Abdollahi, M., 2015. Effectiveness of probiotics in irritable bowel syndrome: updated systematic review with meta-analysis. World Journal of Gastroenterology 21: 3072-3084.
'Effectiveness of probiotics in irritable bowel syndrome: updated systematic review with meta-analysis ' () 21 World Journal of Gastroenterology : 3072 -3084.
Dinan, T.G., Stanton, C. and Cryan, J.F., 2013. Psychobiotics: a novel class of psychotropic. Biological Psychiatry 74: 720-726.
'Psychobiotics: a novel class of psychotropic ' () 74 Biological Psychiatry : 720 -726.
Food and Agriculture Organisation / World Health Organisation (FAO/WHO), 2001. Probiotics in food. Health and nutritional properties and guidelines for evaluation. Joint FAO/WHO expert consultation on evaluation of health and nutritional properties of prebiotics in food including powder milk with live lactic acid bacteria. Food and Nutrition Paper 85. FAO/WHO, Rome, Italy.
Francavilla, R., Miniello, V., Magista, A.M., De Canio, A., Bucci, N., Gagliardi, F., Lionetti, E., Castellaneta, S., Polimeno, L., Peccarisi, L., Indrio, F. and Cavallo, L., 2010. A randomized controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics 126: e1445-e1452.
'A randomized controlled trial of Lactobacillus GG in children with functional abdominal pain ' () 126 Pediatrics : e1445 -e1452.
Galland, L., 2014. The gut microbiome and the brain. Journal of Medicinal Food 17: 1261-1272.
'The gut microbiome and the brain ' () 17 Journal of Medicinal Food : 1261 -1272.
Gawrońska, A., Dziechciarz, P., Horvath, A. and Szajewska, H., 2007. A randomized double-blind placebo-controlled trial of Lactobacillus GG for abdominal pain disorders in children. Alimentary Pharmacology and Therapeutics 25: 177-184.
'A randomized double-blind placebo-controlled trial of Lactobacillus GG for abdominal pain disorders in children ' () 25 Alimentary Pharmacology and Therapeutics : 177 -184.
Glass, J.M., 2008. Fibromyalgia and cognition. Journal of Clinical Psychiatry 69, Suppl. 2: 20-24.
'Fibromyalgia and cognition ' () 69 Journal of Clinical Psychiatry : 20 -24.
Groeger, D., O’Mahony, L., Murphy, E.F., Bourke, J.F., Dinan, T.G., Kiely, B., Shanahan, F. and Quigley, E.M., 2013. Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut. Gut Microbes 4: 325-339.
'Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut ' () 4 Gut Microbes : 325 -339.
Halpern, S.H. and Douglas, M.J., 2005. Appendix: Jadad scale for reporting randomized controlled trials. In: Halpern, S.H. and Douglas, M.J. (eds.) Evidence-based obstetric anesthesia. Blackwell Publishing Ltd., Oxford, UK, pp. 237-238.
'Appendix: Jadad scale for reporting randomized controlled trials ', in Evidence-based obstetric anesthesia , () 237 -238.
Hardy, H., Harris, J., Lyon, E., Beal, J. and Foey, A.D., 2013. Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology. Nutrients 5: 1869-1912.
'Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology ' () 5 Nutrients : 1869 -1912.
Higgins, J.P. and Green, S., 2011. Cochrane handbook for systematic reviews of interventions, version 5.1.0. The Cochrane Collaboration, London, UK.
'Cochrane handbook for systematic reviews of interventions, version 5.1.0 ' () The Cochrane Collaboration, London, UK .
Jadad, A.R., Moore, R.A., Carroll, D., Jenkinson, C., Reynolds, D.J., Gavaghan, D.J. and McQuay, H.J., 1996. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clinical Trials 17: 1-12.
'Assessing the quality of reports of randomized clinical trials: is blinding necessary? ' () 17 Controlled Clinical Trials : 1 -12.
Jenks, K., Stebbings, S., Burton, J., Schultz, M., Herbison, P. and Highton, J., 2010. Probiotic therapy for the treatment of spondyloarthritis: a randomized controlled trial. Journal of Rheumatology 37: 2118-2125.
'Probiotic therapy for the treatment of spondyloarthritis: a randomized controlled trial ' () 37 Journal of Rheumatology : 2118 -2125.
Jones, G., Atzeni, F., Beasley, M., Flüβ, E., Sarzi-Puttini, P. and Macfarlane, G.J., 2015. The prevalence of fibromyalgia in the general population: a comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria. Arthritis and Rheumatology 67: 568-575.
'The prevalence of fibromyalgia in the general population: a comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria ' () 67 Arthritis and Rheumatology : 568 -575.
Jones, J.F., Nisenbaum, R. and Reeves, W.C., 2003. Medication use by persons with chronic fatigue syndrome: results of a randomized telephone survey in Wichita, Kansas. Health and Quality of Life Outcomes 1: 74.
'Medication use by persons with chronic fatigue syndrome: results of a randomized telephone survey in Wichita, Kansas ' () 1 Health and Quality of Life Outcomes : 74.
Joyce, E., Blumenthal, S. and Wessely, S., 1996. Memory, attention, and executive function in chronic fatigue syndrome. Journal of Neurology, Neurosurgery, and Psychiatry 60: 495-503.
'Memory, attention, and executive function in chronic fatigue syndrome ' () 60 Journal of Neurology, Neurosurgery, and Psychiatry : 495 -503.
Kanaan, R.A.A., Lepine, J.P. and Wessely, S.C., 2007. The association or otherwise of the functional somatic syndromes. Psychosomatic Medicine 69: 855-859.
'The association or otherwise of the functional somatic syndromes ' () 69 Psychosomatic Medicine : 855 -859.
Khalighi, A.R., Khalighi, M.R., Behdani, R., Jamali, J., Khosravi, A., Kouhestani, S., Radmanesh, H., Esmaeelzadeh, S. and Khalighi, N., 2014. Evaluating the efficacy of probiotic on treatment in patients with small intestinal bacterial overgrowth (SIBO) – a pilot study. Indian Journal of Medical Research 140: 604-608.
'Evaluating the efficacy of probiotic on treatment in patients with small intestinal bacterial overgrowth (SIBO) – a pilot study ' () 140 Indian Journal of Medical Research : 604 -608.
Lakhan, S.E. and Kirchgessner, A., 2010. Gut inflammation in chronic fatigue syndrome. Nutrition & Metabolism 7: 79.
'Gut inflammation in chronic fatigue syndrome ' () 7 Nutrition & Metabolism : 79.
Lee, J.-Y., Chu, S.-H., Jeon, J.Y., Lee, M.-K., Park, J.-H., Lee, D.-C., Lee, J.W. and Kim, N.-K., 2014. Effects of 12 weeks of probiotic supplementation on quality of life in colorectal cancer survivors: a double-blind, randomized, placebo-controlled trial. Digestive and Liver Disease 46: 1126-1132.
'Effects of 12 weeks of probiotic supplementation on quality of life in colorectal cancer survivors: a double-blind, randomized, placebo-controlled trial ' () 46 Digestive and Liver Disease : 1126 -1132.
Lorenzo-Zúñiga, V., Llop, E., Suárez, C., Alvarez, B., Abreu, L., Espadaler, J. and Serra, J., 2014. I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life. World Journal of Gastroenterology 20: 8709-8716.
'I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life ' () 20 World Journal of Gastroenterology : 8709 -8716.
Maes, M., Kubera, M. and Leunis, J.-C., 2008. The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinology Letters 29: 117-124.
'The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression ' () 29 Neuro Endocrinology Letters : 117 -124.
Mandel, D.R., Eichas, K. and Holmes, J., 2010. Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial. BMC Complementary and Alternative Medicine 10: 1.
'Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial ' () 10 BMC Complementary and Alternative Medicine : 1.
Martinowich, K. and Lu, B., 2008. Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology 33: 73-83.
'Interaction between BDNF and serotonin: role in mood disorders ' () 33 Neuropsychopharmacology : 73 -83.
Messaoudi, M., Lalonde, R., Violle, N., Javelot, H., Desor, D., Nejdi, A., Bisson, J.F., Rougeot, C., Pichelin, M., Cazaubiel, M. and Cazaubiel, J.-M., 2011a. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. British Journal of Nutrition 105: 755-764.
'Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects ' () 105 British Journal of Nutrition : 755 -764.
Messaoudi, M., Violle, N., Bisson, J.-F., Desor, D., Javelot, H. and Rougeot, C., 2011b. Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in healthy human volunteers. Gut Microbes 2: 256-261.
'Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in healthy human volunteers ' () 2 Gut Microbes : 256 -261.
Michalsen, A., Riegert, M., Lüdtke, R., Bäcker, M., Langhorst, J., Schwickert, M. and Dobos, G.G.J., 2005. Mediterranean diet or extended fasting’s influence on changing the intestinal microflora, immunoglobulin A secretion and clinical outcome in patients with rheumatoid arthritis and fibromyalgia: an observational study. BMC Complementary and Alternative Medicine 5: 22.
'Mediterranean diet or extended fasting’s influence on changing the intestinal microflora, immunoglobulin A secretion and clinical outcome in patients with rheumatoid arthritis and fibromyalgia: an observational study ' () 5 BMC Complementary and Alternative Medicine : 22.
Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G.D. and the PRISMA Group, 2009. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Medicine 6: e1000097.
'Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement ' () 6 PLoS Medicine : e1000097.
Penfold, S., St. Denis, E. and Mazhar, M.N., 2016. The association between borderline personality disorder, fibromyalgia and chronic fatigue syndrome: systematic review. British Journal of Psychiatry Open 2: 275-279.
'The association between borderline personality disorder, fibromyalgia and chronic fatigue syndrome: systematic review ' () 2 British Journal of Psychiatry Open : 275 -279.
Petschow, B., Doré, J., Hibberd, P., Dinan, T., Reid, G., Blaser, M., Cani, P.D., Degnan, F.H., Foster, J., Gibson, G., Hutton, J., Klaenhammer, T.R., Ley, R., Nieuwdorp, M., Pot, B., Relman, D., Serazin, A. and Sanders, M.E., 2013. Probiotics, prebiotics, and the host microbiome: the science of translation. Annals of the New York Academy of Sciences 1306: 1-17.
'Probiotics, prebiotics, and the host microbiome: the science of translation ' () 1306 Annals of the New York Academy of Sciences : 1 -17.
Pimentel, M., Chow, E.J. and Lin, H.C., 2003. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study. American Journal of Gastroenterology 98: 412-419.
'Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome ' () 98 American Journal of Gastroenterology : 412 -419.
Pimentel, M., Wallace, D., Hallegua, D., Chow, E., Kong, Y., Park, S. and Lin, H.C., 2004. A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing. Annals of the Rheumatic Diseases 63: 450-452.
'A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing ' () 63 Annals of the Rheumatic Diseases : 450 -452.
Rao, A.V., Bested, A.C., Beaulne, T.M., Katzman, M.A., Iorio, C., Berardi, J.M. and Logan, A.C., 2009. A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathogens 1: 6.
'A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome ' () 1 Gut Pathogens : 6.
Riedl, A., Schmidtmann, M., Stengel, A., Goebel, M., Wisser, A.-S., Klapp, B.F. and Mönnikes, H., 2008. Somatic comorbidities of irritable bowel syndrome: a systematic analysis. Journal of Psychosomatic Research 64: 573-582.
'Somatic comorbidities of irritable bowel syndrome: a systematic analysis ' () 64 Journal of Psychosomatic Research : 573 -582.
Ringel-Kulka, T., Goldsmith, J.R., Carroll, I.M., Barros, S.P., Palsson, O., Jobin, C. and Ringel, Y., 2014. Lactobacillus acidophilus NCFM affects colonic mucosal opioid receptor expression in patients with functional abdominal pain – a randomised clinical study. Alimentary Pharmacology and Therapeutics 40: 200-207.
'Lactobacillus acidophilus NCFM affects colonic mucosal opioid receptor expression in patients with functional abdominal pain – a randomised clinical study ' () 40 Alimentary Pharmacology and Therapeutics : 200 -207.
Roman, P., Estevez, A.F., Sánchez-Labraca, N., Cañadas, F., Miras, A. and Cardona, D., 2017. Probiotics for fibromyalgia: study design for a pilot double-blind, randomized controlled trial. Nutrición Hospitalaria 34: 1285-1290.
'Probiotics for fibromyalgia: study design for a pilot double-blind, randomized controlled trial ' () 34 Nutrición Hospitalaria : 1285 -1290.
Sheedy, J.R., Wettenhall, R.E.H., Scanlon, D., Gooley, P.R., Lewis, D.P., McGregor, N., Stapleton, D.I., Butt, H.L. and Meirleir, K.L., 2009. Increased d-lactic acid intestinal bacteria in patients with chronic fatigue syndrome. In vivo 23: 621-628.
'Increased d-lactic acid intestinal bacteria in patients with chronic fatigue syndrome ' () 23 In vivo : 621 -628.
Sherwin, E., Rea, K., Dinan, T.G. and Cryan, J.F., 2016. A gut (microbiome) feeling about the brain. Current Opinion in Gastroenterology 32: 96-102.
'A gut (microbiome) feeling about the brain ' () 32 Current Opinion in Gastroenterology : 96 -102.
Silk, D.B.A., Davis, A., Vulevic, J., Tzortzis, G. and Gibson, G.R., 2009. Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Alimentary Pharmacology and Therapeutics 29: 508-518.
'Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome ' () 29 Alimentary Pharmacology and Therapeutics : 508 -518.
Slim, M., Calandre, E.P. and Rico-Villademoros, F., 2015. An insight into the gastrointestinal component of fibromyalgia: clinical manifestations and potential underlying mechanisms. Rheumatology International 35: 433-444.
'An insight into the gastrointestinal component of fibromyalgia: clinical manifestations and potential underlying mechanisms ' () 35 Rheumatology International : 433 -444.
Sperber, A.D., Atzmon, Y., Neumann, L., Weisberg, I., Shalit, Y., Abu-Shakrah, M., Fich, A., Buskila, D., 1999. Fibromyalgia in the irritable bowel syndrome: studies of prevalence and clinical implications. American Journal of Gastroenterology 94: 3541-3546.
'Fibromyalgia in the irritable bowel syndrome: studies of prevalence and clinical implications ' () 94 American Journal of Gastroenterology : 3541 -3546.
Steenbergen, L., Sellaro, R., Van Hemert, S., Bosch, J.A. and Colzato, L.S., 2015. A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain, Behavior, and Immunity 48: 258-264.
'A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood ' () 48 Brain, Behavior, and Immunity : 258 -264.
Stone, P.W., 2002. Popping the (PICO) question in research and evidence-based practice. Applied Nursing Research 15: 197-198.
'Popping the (PICO) question in research and evidence-based practice ' () 15 Applied Nursing Research : 197 -198.
Sullivan, A., Nord, C.E. and Evengård, B., 2009. Effect of supplement with lactic-acid producing bacteria on fatigue and physical activity in patients with chronic fatigue syndrome. Nutrition Journal 8: 4.
'Effect of supplement with lactic-acid producing bacteria on fatigue and physical activity in patients with chronic fatigue syndrome ' () 8 Nutrition Journal : 4.
Tiequn, B., Guanqun, C. and Shuo, Z., 2015. Therapeutic effects of Lactobacillus in treating irritable bowel syndrome: a meta-analysis. Internal Medicine 54: 243-249.
'Therapeutic effects of Lactobacillus in treating irritable bowel syndrome: a meta-analysis ' () 54 Internal Medicine : 243 -249.
Triadafilopoulos, G., Simms, R.W. and Goldenberg, D.L., 1991. Bowel dysfunction in fibromyalgia syndrome. Digestive Diseases and Sciences 36: 59-64.
'Bowel dysfunction in fibromyalgia syndrome ' () 36 Digestive Diseases and Sciences : 59 -64.
Umbrello, G. and Esposito, S., 2016. Microbiota and neurologic diseases: potential effects of probiotics. Journal of Translational Medicine 14: 298.
'Microbiota and neurologic diseases: potential effects of probiotics ' () 14 Journal of Translational Medicine : 298.
Upadhyay, N. and Moudgal, V., 2012. Probiotics: a review. Journal of Clinical Outcomes Management 19: 76-84.
'Probiotics: a review ' () 19 Journal of Clinical Outcomes Management : 76 -84.
Whitehead, W.E., Palsson, O. and Jones, K.R., 2002. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 122: 1140-1156.
'Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? ' () 122 Gastroenterology : 1140 -1156.
Wolfe, F., Clauw, D.J., Fitzcharles, M.-A., Goldenberg, D.L., Häuser, W., Katz, R.S., Mease, P., Russell, A.S., Russell, I.J. and Winfield, J.B., 2011. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia. Journal of Rheumatology 38: 1113-1122.
'Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia ' () 38 Journal of Rheumatology : 1113 -1122.
Wolfe, F., Clauw, D.J., Fitzcharles, M.-A., Goldenberg, D.L., Katz, R.S., Mease, P., Russell, A.S., Russell, I.J., Winfield, J.B. and Yunus, M.B., 2010. The American college of rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care and Research 62: 600-610.
'The American college of rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity ' () 62 Arthritis Care and Research : 600 -610.
Wolfe, F., Smythe, H.A., Yunus, M.B., Bennett, R.M., Bombardier, C., Goldenberg, D.L., Tugwell, P., Campbell, S.M., Abeles, M. and Clark, P., 1990. The American college of rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis and Rheumatism 33: 160-172.
'The American college of rheumatology 1990 criteria for the classification of fibromyalgia ' () 33 Arthritis and Rheumatism : 160 -172.
Zhou, L. and Foster, J.A., 2015. Psychobiotics and the gut-brain axis: in the pursuit of happiness. Neuropsychiatric Disease and Treatment 11: 715-723.
'Psychobiotics and the gut-brain axis: in the pursuit of happiness ' () 11 Neuropsychiatric Disease and Treatment : 715 -723.
All Time | Past 365 days | Past 30 Days | |
---|---|---|---|
Abstract Views | 1216 | 978 | 193 |
Full Text Views | 27 | 17 | 3 |
PDF Views & Downloads | 46 | 35 | 7 |
Evidence suggests that the gut microbiota might play an important role in fibromyalgia syndrome (FMS) and chronic fatigue syndrome (CFS). Our goal is to systematically review the reported effect of probiotic treatments in patients diagnosed with FMS or CFS. A systematic review was carried out using 14 databases (PubMed, Cochrane Library, Scopus, PsycINFO, and others) in February 2016 to search for randomised controlled trials (RCTs) and pilot studies of CFS or FMS patient, published in the last ten years (from 2006 to 2016). The Jadad scale was used to asseverate the quality of the clinical trials considered. Two studies (n=83) met the inclusion criteria, which were performed in CFS patients and both studies were considered as a ‘High range of quality score’. The administration of Lactobacillus casei strain Shirota in CFS patients, over the course of 8 weeks, reduced anxiety scores. Likewise, this probiotic changed the faecal composition following 8 weeks of treatment. Additionally, the treatment with Bifidobacterium infantis 35624 in CFS patients, during the same period, reduced inflammatory biomarkers. The evidence about the usefulness of probiotics in CFS and FMS patients remains limited. The studied strains of probiotics have demonstrated a significant effect on modulating the anxiety and inflammatory processes in CFS patients. However, more experimental research, focusing mainly on the symptoms of the pathologies studied, is needed.
All Time | Past 365 days | Past 30 Days | |
---|---|---|---|
Abstract Views | 1216 | 978 | 193 |
Full Text Views | 27 | 17 | 3 |
PDF Views & Downloads | 46 | 35 | 7 |